• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Inflammation and clinical response to treatment in depression: A meta-analysis

Sidereal

Senior Member
Messages
4,856
Eur Neuropsychopharmacol. 2015 Jun 20. pii: S0924-977X(15)00177-7. doi: 10.1016/j.euroneuro.2015.06.007. [Epub ahead of print]
Inflammation and clinical response to treatment in depression: A meta-analysis.
Strawbridge R1, Arnone D2, Danese A3, Papadopoulos A2, Herane Vives A4, Cleare AJ5.
Author information
  • 1Affective Disorders Research Group, Centre for Affective Disorders, Psychological Medicine, Institute of Psychiatry, King׳s College London, London, UK. Electronic address: Becci.strawbridge@kcl.ac.uk.
  • 2Affective Disorders Research Group, Centre for Affective Disorders, Psychological Medicine, Institute of Psychiatry, King׳s College London, London, UK.
  • 3Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, King׳s College London, London, UK; Department of Child & Adolescent Psychiatry, Institute of Psychiatry, King׳s College London, London, UK.
  • 4Affective Disorders Research Group, Centre for Affective Disorders, Psychological Medicine, Institute of Psychiatry, King׳s College London, London, UK; Psychiatric University Clinic, University of Chile, Santiago, Chile.
  • 5Affective Disorders Research Group, Centre for Affective Disorders, Psychological Medicine, Institute of Psychiatry, King׳s College London, London, UK; National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King׳s College London, London, UK.
Abstract
The depressive state has been characterised as one of elevated inflammation, which holds promise for better understanding treatment-resistance in affective disorders as well as for future developments in treatment stratification.

Aiming to investigate alterations in the inflammatory profiles of individuals with depression as putative biomarkers for clinical response, we conducted a meta-analyses examining data from 35 studies that investigated inflammation before and after treatment in depressed patients together with a measure of clinical response.

There were sufficient data to analyse IL-6, TNFα and CRP. Levels of IL-6 decreased with antidepressant treatment regardless of outcome, whereas persistently elevated TNFα was associated with prospectively determined treatment resistance. Treatment non-responders tended to have higher baseline inflammation, using a composite measure of inflammatory markers.

Our findings suggest that elevated levels of inflammation are contributory to treatment resistance. Combining inflammatory biomarkers might prove a useful tool to improve diagnosis and detection of treatment refractoriness, and targeting persistent inflammation in treatment-resistant depression may offer a potential target for the development of novel intervention strategies.

http://www.ncbi.nlm.nih.gov/pubmed/26169573
 
Messages
3,263
Interesting, @Sidereal. The more I learn about depression, the more I think its actually a messy mix of a number of very different chronic conditions, but our way of describing and diagnosing it is so blunt, we can't even see the differences.

Important, too, to point out that despite the evidence suggesting a biomarker for this particular form of "treatment resistant depression", these authors still maintain that the cause of the depression is psychosocial:

The causative effect of psychological and physiological stress on the inflammatory response has been well documented and this system interacts bidirectionally with other systems implicated in mood disorders, including HPA-axis activity and cortisol release (Miller et al., 1999), serotonergic pathways (Maes et al., 2011), neurogenesis and neuroinflammation(Harry and Kraft, 2012).

They then go on to give examples where inflammatory responses and depression-like symptoms have been induced by purely biological interventions, without psychosocial stressors (e.g., interferon). Which would seem to be a much simpler explanation.

So instead of this:

inflammation -> disorder that looks a bit like depression, but is fundamentally different (nice simple explanation)

We have this:

psychosocial stressors -> inflammation -> depression (byzantine model that pleases those with a biopsychosocial bent)

Hey, you can have your cake and eat it - biomarkers and psychobabble!
 

Sidereal

Senior Member
Messages
4,856
Is anyone willing to admit they've been mistakenly treating inflammatory diseases with counseling and mood elevators, to say nothing of possible electroconvulsive therapy?

Why would that be a mistake? Antidepressants have anti-inflammatory effects. They work well for a minority of patients.

Interesting, @Sidereal. The more I learn about depression, the more I think its actually a messy mix of a number of very different chronic conditions, but our way of describing and diagnosing it is so blunt, we can't even see the differences.

I agree. Their own meta-analyses show extremely high levels of heterogeneity. In fairness, they do acknowledge that in the discussion.

In addition, depression is a highly diverse condition and this was evident in the significant levels of heterogeneity present in analyses, with factors including severity, depressive subtype, and degree of treatment resistance likely contributing to variation in inflammatory profiles. We explored possible sources of heterogeneity with meta-regression analyses and found some associations with effect sizes, notably those present in the composite analyses, and that IL-6 reductions with treatment were more prominent in younger samples. This may be a proxy for an earlier stage within the longitudinal course of affective illness or a representation of treatment naivety; both of these factors are associated with improved clinical response (Kornstein and Schneider, 2001). However, it is important to bear in mind that heterogeneity could only partially be explained by the confounders we considered in meta-regressions; indeed, it is likely that there is significant heterogeneity due to the very nature of depression itself. Moreover, this reinforces our message that further progress will be facilitated by defining more homogeneous groups for study, for example those with raised inflammatory markers and/or specific symptom profiles.
 

Marco

Grrrrrrr!
Messages
2,386
Location
Near Cognac, France
Interesting, @Sidereal. The more I learn about depression, the more I think its actually a messy mix of a number of very different chronic conditions, but our way of describing and diagnosing it is so blunt, we can't even see the differences.

Thankfully at least partially adressed in this particular genetics study. Large scale gene studies of 'undifferentiated' cases of depression found nothing.

More than 350 million people have depression. The disorder’s symptoms and severity can vary widely from one person to the next, and particularly between men and women. This suggests that different conditions have been lumped together into one diagnosis, complicating genetic analyses.

The few hits from early studies attempting to find genetic sequences linked to depression had disappeared on closer scrutiny, so Flint knew that he would need samples from thousands of people, and a way to reduce the variability in their illness. Flint and Kenneth Kendler, a psychiatrist at Virginia Commonwealth University in Richmond who is renowned for his diagnostic prowess, decided to do the study in China, because of its large population and because depression is believed to be under-diagnosed there. In that climate, Flint reasoned, those who are diagnosed are likely to share a severe form of the disorder. To reduce the variability further, his team also limited the study to women of Han Chinese ethnicity.

http://www.nature.com/news/first-robust-genetic-links-to-depression-emerge-1.17979
 

user9876

Senior Member
Messages
4,556
Interesting, @Sidereal. The more I learn about depression, the more I think its actually a messy mix of a number of very different chronic conditions, but our way of describing and diagnosing it is so blunt, we can't even see the differences.

I wonder if this is a problem in diagnosing without really trying to get to grips with the details of symptoms. Would all depressed patients describe depressed in the same way. Or with fatigue do all fatigued patients experience the same thing - is cancer fatigue the same as with ME?

Sometimes I think doctors need to look in more detail rather than having some words with very broad semantics and a tick box diagnosis system.

Important, too, to point out that despite the evidence suggesting a biomarker for this particular form of "treatment resistant depression", these authors still maintain that the cause of the depression is psychosocial:



They then go on to give examples where inflammatory responses and depression-like symptoms have been induced by purely biological interventions, without psychosocial stressors (e.g., interferon). Which would seem to be a much simpler explanation.

So instead of this:

inflammation -> disorder that looks a bit like depression, but is fundamentally different (nice simple explanation)

We have this:

psychosocial stressors -> inflammation -> depression (byzantine model that pleases those with a biopsychosocial bent)

Hey, you can have your cake and eat it - biomarkers and psychobabble!

Could it be that we have event->inflammation -> ... -> depression (or other symptoms) but where the ....s are there is a transition where things are not quite working right as the inflammation (or other mechanisms) builds up. As things are not working correctly people get stressed because they can't get everything done they need to. So that to an observer they might see stress -> depression since other bits won't be observed. Of course there may just be an over reporting of stress due to the framing of doctors and hence it comes to patients minds.
 

A.B.

Senior Member
Messages
3,780
So instead of this:

inflammation -> disorder that looks a bit like depression, but is fundamentally different (nice simple explanation)

We have this:

psychosocial stressors -> inflammation -> depression (byzantine model that pleases those with a biopsychosocial bent)

The streetlight effect is a type of observational bias where people only look for whatever they are searching by looking where it is easiest.[1][2][3] The search itself may be referred to as a drunkard's search.

Taken from an old joke about a drunkard who is searching for something he has lost, the parable is told several ways but typically includes the following details:

A policeman sees a drunk man searching for something under a streetlight and asks what the drunk has lost. He says he lost his keys and they both look under the streetlight together. After a few minutes the policeman asks if he is sure he lost them here, and the drunk replies, no, and that he lost them in the park. The policeman asks why he is searching here, and the drunk replies, "this is where the light is."[2]

https://en.wikipedia.org/wiki/Streetlight_effect

Maybe depression is actually simple to explain but we've been searching under the streetlight for the last 100 years, and by now have research institutions that specialize in searching under streetlights.
 
Last edited:

anciendaze

Senior Member
Messages
1,841
Why would that be a mistake? Antidepressants have anti-inflammatory effects. They work well for a minority of patients...
Antidepressants started life as repurposed antibiotics aimed at treating tuberculosis. (See the history of isoniazid.) You have to go a long way in the literature before you encounter any mention of anti-inflammatory properties. There are multiple historical roots for antidepressant development, and the discovery that entirely different lines of development resulted in drugs with some anti-inflammatory properties, still not well understood, should have been an indication that the central tenets of their mechanisms of action were wrong. Most of these drugs exhibit immunomodulatory effects which are very poorly explained. Finally, we have the stunning discovery that SSRIs have powerful effects on enteroviruses, something that was emphatically never intended.

This is particularly ironic because fluoxetine, the leading example of an SSRI, was described as the result of "rational drug design". Some consequences of sheer ignorance in this process would be hard to imagine without the aid of psychoactive substances.
 

Sidereal

Senior Member
Messages
4,856
Antidepressants started life as repurposed antibiotics aimed at treating tuberculosis. (See the history of isoniazid.) You have to go a long way in the literature before you encounter any mention of anti-inflammatory properties. There are multiple historical roots for antidepressant development, and the discovery that entirely different lines of development resulted in drugs with some anti-inflammatory properties, still not well understood, should have been an indication that the central tenets of their mechanisms of action were wrong.

The treatments you dissed in your original post are effective for some patients with depression, some of whom have a severely disabling, treatment resistant and/or life-threatening illness. The fact that we don't know how they work or that MAO inhibitors and TCAs were serendipitously discovered or that SSRIs were developed based on the flawed serotonin hypothesis or that drugs have unintended effects is irrelevant. Everyone is wrong about disease and treatment mechanisms all the time, there is nothing unusual going on in that regard here. These treatments will continue to be used until better ones are developed because they are somewhat effective which is a preferable situation to disability or suicide.

It is becoming evident that antidepressants ultimately work via an immunomodulatory mechanism. I would invite you to take a look at some of the newer work showing that the effect of SSRI is diminished if the patient is taking NSAID like ibuprofen at the same time.

http://www.pnas.org/content/108/22/9262.full

Antiinflammatory drugs achieve their therapeutic actions at least in part by regulation of cytokine formation. A “cytokine hypothesis” of depression is supported by the observation that depressed individuals have elevated plasma levels of certain cytokines compared with healthy controls. Here we investigated a possible interaction between antidepressant agents and antiinflammatory agents on antidepressant-induced behaviors and on p11, a biochemical marker of depressive-like states and antidepressant responses. We found that widely used antiinflammatory drugs antagonize both biochemical and behavioral responses to selective serotonin reuptake inhibitors (SSRIs). In contrast to the levels detected in serum, we found that frontal cortical levels of certain cytokines (e.g., TNFα and IFNγ) were increased by serotonergic antidepressants and that these effects were inhibited by antiinflammatory agents. The antagonistic effect of antiinflammatory agents on antidepressant-induced behaviors was confirmed by analysis of a dataset from a large-scale real-world human study, “sequenced treatment alternatives to relieve depression” (STAR*D), underscoring the clinical significance of our findings. Our data indicate that clinicians should carefully balance the therapeutic benefits of antiinflammatory agents versus the potentially negative consequences of antagonizing the therapeutic efficacy of antidepressant agents in patients suffering from depression.

Immune modulators are being studied for depression now. For example, infliximab, a TNF-a antagonist, showed a signal in a subgroup analysis of patients with depression with elevated CRP at baseline in this small underpowered trial:

http://archpsyc.jamanetwork.com/article.aspx?articleid=1356541

You'll notice that the response rate to infliximab in this group of depressed patients was essentially the same as the response rate to rituximab in ME/CFS but in the depression trial the effect was not statistically significant because depression trials are plagued by a high placebo response rate which makes it very hard to detect treatment effects whereas the likelihood of placebo response in properly characterised ME cohorts is low.
 

duncan

Senior Member
Messages
2,240
The reasons treatments work, or do not, needs desperately to be relevant.

If we are throwing treatments at patients without understanding the mechanisms behind their success, that is dangerous ground that threatens to lead to bad consequences.
 

Sidereal

Senior Member
Messages
4,856
The reasons treatments work, or do not, needs desperately to be relevant.

If we are throwing treatments at patients without understanding the mechanisms behind their success, that is dangerous ground that threatens to lead to bad consequences.

Agreed. A lot of psychiatry is a cargo cult science as far as I'm concerned. But that doesn't mean psychiatry should apologise for using currently available effective treatments for depression just because they were developed by accident or based on incorrect or incomplete hypotheses.
 

anciendaze

Senior Member
Messages
1,841
@Sidereal

The research you cite is still largely unknown to practitioners, or considered uncertain, as opposed to "proven treatments". Those who do not respond have "treatment-resistant depression", not a misdiagnosis. Psychiatric diagnoses may be falsified by discovery of physiological disease, but can seldom be falsified with any confidence within psychiatry. This is a clear weakness.

What is far from hypothetical is the effect on patients with definite physiological disease thrown into this category. I know of a case in which a patient with miliary TB died during ECT. Patients with Wilson's disease may sit in back wards for years with complex psychiatric diagnoses before anyone notices the pathognomonic sign of a copper ring around the iris. This is not speculation; it has happened.

I've gone one round with a local doctor concerning a patient with an actual clear diagnosis of POTS who committed suicide in a spectacular manner. Counseling and drugs to reduce anxiety were not the answer to the problem of her brain not getting oxygenated blood, with resulting poor decision making. The argument that she must have had hidden depression, since she killed herself, takes us into circular reasoning, and entirely beyond the scope of objective science.

Doctors tend to interpret POTS as simply a problem with heart rate and anxiety. Neurally-mediated hypotension is often interpreted in terms of conventional numbers for systolic or diastolic pressure, and presumed mental problems. These are relatively simple physical problems producing objective measurements. I've repeatedly encountered doctors who flatly reject the idea that upright pulse pressure will decline over about 20 minutes, and refuse to make any measurements which might show this.

When a patient showing such obvious signs of distress is faced with the prospect of being put in a locked ward, where serious physiological problems are regularly neglected, suicide becomes predictable.

I'm not arguing that all cases of clinical depression are misdiagnoses, or that antidepressants do not have uses in keeping patients alive for the months that many cases last. I am arguing that we seldom know what is going on inside psychiatric patients, and must be especially careful about ignoring physiological causes of irrational behavior.
 

natasa778

Senior Member
Messages
1,774
T
.... SSRIs were developed based on the flawed serotonin hypothesis or that drugs have unintended effects is irrelevant. Everyone is wrong about disease and treatment mechanisms all the time, there is nothing unusual going on in that regard here. These treatments will continue to be used until better ones are developed because they are somewhat effective which is a preferable situation to disability or suicide.

It is becoming evident that antidepressants ultimately work via an immunomodulatory mechanism. I would invite you to take a look at some of the newer work showing that the effect of SSRI is diminished if the patient is taking NSAID like ibuprofen at the same time.

Did you see that article I posted on central mediating role of serotonin in the effects of peripheral inflammation on CNS function.

It could well be the case of that street lamp being in the middle of the park :)
 

Sidereal

Senior Member
Messages
4,856
Did you see that article I posted on central mediating role of serotonin in the effects of peripheral inflammation on CNS function.

It could well be the case of that street lamp being in the middle of the park :)

Sorry, I don't think I have. Could you post a link?
 

natasa778

Senior Member
Messages
1,774
Sorry, I don't think I have. Could you post a link?

here is the original paper, I cannot find the link to the thread (I might have dreamt posting it :))

http://www.jneuroinflammation.com/content/pdf/1742-2094-10-116.pdf

Our results suggest that genetic deletion of the serotonin transporter in rats is associated with alterations of
immune/inflammatory players, such as proinflammatory cytokines and markers of microglia activation
, under basal
conditions or following an immune challenge. These results support the idea of a close and reciprocal modulation
between a gene strongly associated with depression and systems involved in the immune response, in line with the
idea that inflammation represents an important environmental factor for depression susceptibility ...
 

Sidereal

Senior Member
Messages
4,856
here is the original paper, I cannot find the link to the thread (I might have dreamt posting it :))

http://www.jneuroinflammation.com/content/pdf/1742-2094-10-116.pdf

Okay, a rat study. Nonetheless, it raises the important point that you require key additional factors to be present in the body in order to be capable of developing a major depressive episode when in a state of immune activation. You can observe this anecdotally in your social circle when people get infections. Some people get very irritable, foul mood, negative/irrational/perseverative cognitions, anxiety etc. when they have a cold while others get no apparent depressive symptoms despite having an infection/autoimmune disease/cancer/etc.
 
Messages
3,263
Interesting and related observation: When I started on prednisone, I had a look at various forums to see if anyone had suffered depression on it (I saw it mentioned somewhere as a side effect of long-term use).

But what I discovered was the opposite: a lot of people with depression who had never responded to antidepressants, but found when they took a course of prednisone (usually prescribed for something else entirely), they felt a marked and long-lasting relief from their depression.

Given that corticosteroids are immune suppressants, just wondering is these guys might be the "non-responders" whose depression is inflammation-related?
 

A.B.

Senior Member
Messages
3,780
But what I discovered was the opposite: a lot of people with depression who had never responded to antidepressants, but found when they took a course of prednisone (usually prescribed for something else entirely), they felt a marked and long-lasting relief from their depression.

Given that corticosteroids are immune suppressants, just wondering is these guys might be the "non-responders" whose depression is inflammation-related?
Corticosteroids are known to improve mood in most people so this isn't very surprising.